Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PHYSICAL SCIENCES INC.
- Proposal award date
- 2021-09-23
- Contract end date
- 2022-09-22
- UEI
- RMG1AZ1ZH8Q7
- Solicitation number
- PA20-260
- Topic code
- NIBIB
Research abstract
Project Summary/Abstract
Physical Sciences Inc. (PSI), in collaboration with the Department of Radiology at Brigham and Womenandapos;s
Hospital (BWH), proposes to develop an automated Smart Multi-grid-guidance Template (SMT) technology
that will enable magnetic resonance imaging (MRI)-guided transperineal focal therapy improvement of prostate
cancer (PCa). Focal therapy that targets localized PCa lesions is a growing therapeutic option for PCa patients
with unifocal, low- and intermediate-risk cancer. Various energy therapy modalities, such as cryoablation,
laser ablation, radiofrequency ablation, high-intensity focused ultrasound, have been clinically investigated
with regards to improving post-treatment preservation of sexual and urinary function while focally treating
PCa. Although these PCa focal therapy modalities have widely been utilized in conjunction with the imaging-
guided approaches for precise localization of PCa lesions, accurate placement of the therapy needles within
the PCa lesions remains a major challenging problem in improving the PCa therapy success rate. Therefore,
there is a clinical need for a technology that can provide highly accurate placement of multiple therapy
needles onto the targeted PCa lesions during focal therapy. During Phase I, PSI/BWH team will focus on the
validation of the potential impact of the SMT system on focal cryoablation therapy. A preclinical prototype of
the SMT system will be developed, optimized on a prostate phantom, and then its accuracy for needle
placement will be tested ex vivo on excised animal prostate glands. Additionally, its capability to provide real-
time needle monitoring and accurate placement of multiple therapy needles will be evaluated in vivo on a
large animal model during MRI-guided focal cryoablation procedures. Based on the Phase I results and
conclusions, a robust SMT system with improved performance for clinical use in various focal therapy
modalities will be proposed to be developed and validated on human patients in Phase II.Project Narrative
The central focus of this project is to improve the therapeutic accuracy of MRI-guided transperineal focal
treatment in prostate cancer by providing precise therapy needle placement using a Smart Multi-grid
Template technology. The proposed device will improve the prostate cancer therapy success rate, reduce
the risk of overtreatment for early-stage prostate cancer, and ultimately improve the quality of life for patients
and their families.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
1,763 SBIR/STTR records share this UEI (1983–2026). Reported award amounts total $698,949,224. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Health and Human Services, Department of Energy, National Science Foundation, Environmental Protection Agency
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards